Hematology Analyzers Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 6.23 Billion |
| Market Size (2029) | USD 8.78 Billion |
| CAGR (2024 - 2029) | 7.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Hematology Analyzers Market Analysis
The Hematology Analyzers Market size is estimated at USD 6.23 billion in 2024, and is expected to reach USD 8.78 billion by 2029, growing at a CAGR of 7.10% during the forecast period (2024-2029).
There was an increasing focus on the hematology parameters for the assessment of COVID-19 around the world. Various research studies published provide insight into the effects of the pandemic on the market. For instance, in April 2021, a study published in the National Library of Medicine stated that the ongoing COVID-19 pandemic had an impact on the laboratory hematology community. Nevertheless, the pace of COVID-19 hematology-related research has continued to accelerate and has established the role of laboratory hematology data for many purposes including disease prognosis and outcome. However, initiatives such as partnerships by key market players are expected to increase the market growth. For instance, in January 2021, F. Hoffmann-La Roche AG signed a global business partnership agreement with Sysmex Corporation that allows Roche to distribute Sysmex hematology testing products, including instruments and reagents. Thus, with such initiatives, the market is likely to grow over the forecast period.
The major factors for the growth of the hematology analyzers market include the rising burden of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments. Blood disorders have become a global health issue with different causes and are associated with high mortality. Blood disorders, such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, affect millions of people each year across all age groups. According to the Australian Government, Department of Health and Aged Care report in 2022, more than 330,000 affected infants are born each year (83% sickle cell disorders and 17% thalassaemias), around 7% of pregnant women are carriers of hemoglobin disorders, and over 1% of couples are at risk at a global level.
Similarly, according to the World Federation of Hemophilia report updated July 2022, more than 1,125,000 men worldwide have an inherited bleeding disorder, and 418,000 of those have a severe version of the most undiagnosed disease. Early diagnosis and treatment are the best ways to protect the quality of life of a patient with a blood cell disorder. Hence, the increasing burden of blood disorders is likely to drive the market in the future.
Product launches are another factor in market growth. For instance, in July 2022, CellaVision launched DIFF-Line. CellaVision DC-1 is a single-slide analyzer that automates and digitizes the process of analyzing peripheral blood smears. Thus, such product launches are expected to increase market growth over the forecast period.
However, the high cost of hematology analyzers and time-consuming and stringent regulatory policies associated with the same is restraining the overall market growth.
Hematology Analyzers Market Trends
This section covers the major market trends shaping the Hematology Analyzers Market according to our research experts:
3 Part Hematology Analyzer is the Segment by Instruments Expected to Hold Significant Market Share Over the Forecast Period
A 3-part differential cell counter uses Coulter's Principle to find the size and volume of the cell. The sample is lysed and dissolved into an electrolyte solution in a container, which also holds a smaller container. 3-part hematology analyzer systems are ideally suited for physician office laboratories, clinics, and small hospitals that perform moderately complex testing. There is increased interest in 5-part hematology analyzers, however, 3-part hematology analyzers are more cost-effective for routine hematological tests. Furthermore, with advancements in technology and the availability of these instruments across the world coupled with affordability the market is projected to have notable growth. Similarly, convenience and accurate results are the two major reasons driving the growth of the segment over the forecast period.
Ebola Virus is a serious fatal condition that is caused by 4 different species of virus in human and non-human primates. The virus can spread to people through direct contact with the blood, and body fluids, of the person who is having or died from the Ebola virus. It causes hemorrhagic fever which leads to internal and external bleeding and affects multiple organs. The Ebola outbreak in Uganda was declared on September 20, 2022, and it has already spread to seven regions (Kasanda, Kyegegwa, Bunyangabu, and Kagadi districts beyond the original epicenter in Mubende district, and then to Kampala City and Wakiso). Thus, such outbreaks require proper diagnosis to control the spread of the disease which is expected to increase the demand for 3 part hematology analyzer during the forecast period.
Initiatives such as product launches are another factor in market growth. For instance, in April 2022 Sysmex Europe launched its new three-part differential automated hematology analyzer, XQ-320. It is a robust device with low demands for sample volume, bench space, and maintenance in Europe. Thus, the abovementioned factors are expected to increase market growth during the forecast period.
North America is Expected to Hold Significant Market Share Over the Forecast Period
The market for hematology analyzers in the North American region is growing at a steady pace. This can be attributed to the increasing burden of blood disorders and the growth in the adoption of hematology analyzers by the diagnostic industry. For instance, according to the American Society of Hematology, anemia, which is a common disorder, affects more than three million Americans, particularly women of 'childbearing age. According to the Leukemia and Lymphoma Society in 2021, every three minutes, a person in the United States is diagnosed with blood cancer. An estimated 186,400 people in the United States were diagnosed with leukemia, lymphoma, or melanoma in 2021.
Furthermore, many centers in the state are international leaders in the diagnosis and treatment of blood diseases and collaborate in many research projects to improve diagnosis and treatment options for blood diseases. Many market players are present in the country and are continuously focusing on the development and introduction of novel products. In February 2021 Beckman Coulter launched the DxH 560 AL, a tabletop hematology analyzer designed to reduce time and resource constraints faced by small- to mid-sized laboratories. Similarly, in November 2021, Avricore Health Inc signed a non-exclusive pilot supplier distribution agreement in Canada between HealthTab Inc., a wholly-owned subsidiary, and Abbott, the global healthcare company, concerning the handheld blood chemistry analyzer i-STAT Alinity. Thus, such product launches are expected to increase the adoption of hematology analyzers in the region.
These factors drive the demand for hematology analyzers in the North American region over the forecast period.
Hematology Analyzers Industry Overview
The hematology analyzers market is a fragmented market owing to the presence of various market players. Some of the market players are Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories, Boule Diagnostics AB, F Hoffmann-La Roche Ltd, Hobira Ltd, Nihon Kohden Corporation, Mindray Medical International Limited (Shenzhen Mindray Bio-Medical Electronics Co. Ltd), Siemens Healthineers, and Sysmex Corporation.
Hematology Analyzers Market Leaders
-
Abbott Laboratories
-
HORIBA Ltd
-
Siemens Healthineers
-
Sysmex Corporation
-
Danaher Corporation
*Disclaimer: Major Players sorted in no particular order
Hematology Analyzers Market News
- In May 2022, Nihon Kohden India established a new hematology analyzer reagent factory.
- In March 2022, Mindray launched the BC-700 Series, a revolutionary hematology analyzer series that includes both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.
Hematology Analyzers Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Burden of Blood Disorders
- 4.2.2 Increasing Technological Advancements and Rising Adoption Rates of Automated Hematology Instruments
-
4.3 Market Restraints
- 4.3.1 High Cost of Hematology Analyzers
- 4.3.2 Time-consuming and Stringent Rregulatory Policies
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product Type
- 5.1.1 Instruments
- 5.1.1.1 3 Part Hematology Analyzer
- 5.1.1.2 5 Part Hematology Analyzer
- 5.1.1.3 Point-of-care Testing Hematology Analyzers
- 5.1.1.4 Others
- 5.1.2 Reagents
- 5.1.3 Services
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Clinical Laboratories
- 5.2.3 Research Institutes
- 5.2.4 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 Beckman Coulter Inc. (Danaher Corporation)
- 6.1.3 Bio-Rad Laboratories
- 6.1.4 Boule Diagnostics AB
- 6.1.5 F Hoffmann-La Roche Ltd
- 6.1.6 Horiba Ltd
- 6.1.7 Nihon Kohden Corporation
- 6.1.8 Siemens Healthineers
- 6.1.9 Sysmex Corporation
- 6.1.10 Stratec Biomedical Systems (DIATRON)
- 6.1.11 Ortho Clinical Diagnostics
- 6.1.12 Accurex Biomedical Pvt. Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityHematology Analyzers Industry Segmentation
As per the scope of this report, hematology analyzers are the equipment used to run tests on blood samples, and they are used in the medical field to determine white blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests. The Hematology Analyzers market is Segmented by Product (Instruments, Reagents, and Services), End Users (Hospitals, Clinical Laboratories, Research Institutes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | Instruments | 3 Part Hematology Analyzer |
| 5 Part Hematology Analyzer | ||
| Point-of-care Testing Hematology Analyzers | ||
| Others | ||
| By Product Type | Reagents | |
| Services | ||
| By End User | Hospitals | |
| Clinical Laboratories | ||
| Research Institutes | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Hematology Analyzers Market Research FAQs
How big is the Hematology Analyzers Market?
The Hematology Analyzers Market size is expected to reach USD 6.23 billion in 2024 and grow at a CAGR of 7.10% to reach USD 8.78 billion by 2029.
What is the current Hematology Analyzers Market size?
In 2024, the Hematology Analyzers Market size is expected to reach USD 6.23 billion.
Who are the key players in Hematology Analyzers Market?
Abbott Laboratories, HORIBA Ltd, Siemens Healthineers, Sysmex Corporation and Danaher Corporation are the major companies operating in the Hematology Analyzers Market.
Which is the fastest growing region in Hematology Analyzers Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Hematology Analyzers Market?
In 2024, the North America accounts for the largest market share in Hematology Analyzers Market.
What years does this Hematology Analyzers Market cover, and what was the market size in 2023?
In 2023, the Hematology Analyzers Market size was estimated at USD 5.82 billion. The report covers the Hematology Analyzers Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Hematology Analyzers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Hematology Analyzer Industry Report
Statistics for the 2024 Hematology Analyzer market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Hematology Analyzer analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
